21 Results
000000000000DEFAULT_TR
by 
Hanoğlu, Berçem Dilan, author.
Format: 
El Yazması
Alıntı: 
Increasing doxorubicin (Dox) release from liposomes / Hanoğlu, Berçem Dilan, author.
by 
Demir, Ayşe Banu, author.
Format: 
El Yazması
Alıntı: 
Indentification of doxorubicin drug resistance mechanisms by using genomic techniques/ Demir, Ayşe
by 
Özkıyıcı, Selin, author.
Format: 
El Yazması
Alıntı: 
Development of endosome disruptive peptide and PEG conjugate based doxorubicin delivery system /
by 
Zeybek, Ayça.
Format: 
El Yazması
Alıntı: 
The effect of doxorubicin-albumin magnetic nanoparticles on prostate and lung cancer cells/ Zeybek
by 
Önol, Ayşenur Başar, author.
Format: 
El Yazması
Alıntı: 
Development of doxorubicin loaded liposomes self-assembled with polysaccharides for breast cancer
by 
Gökçe, Begüm, author.
Format: 
El Yazması
Alıntı: 
Doxorubicin.
by 
Alkan, Ayşe Hale, author.
Format: 
El Yazması
Alıntı: 
investigated. Candidate lncRNAs from Doxorubicin, Fas mAB, TNF-alpha and Cisplatin treated HeLa cell line were
by 
Yaylak, Bilge, author.
Format: 
El Yazması
Alıntı: 
/or global circRNAs in apoptotic HeLa cells. Cisplatin (CP), doxorubicin (DOX), Fas mAb(FAS) and
by 
Kankale, Deniz, author.
Format: 
El Yazması
Alıntı: 
widely used anticancer drug. Here, doxorubicin uptake by highly metastatic human breast cancer cell line